menu
    • menu

    Company profile for ClearB Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ClearB is working to develop therapeutic vaccines designed to redirect patients’ immune systems toward functional cure of hepatitis B. Our work is grounded in proprietary insights derived from studying rare-event infection resolution in patients who suffer from chronic hepatitis B.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ClearB TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    530 Virginia Road, Suite 300 Concord, MA 01742
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clearbtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clearb/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ClearB Expands Ph1b CLB-4000 Study for Chronic Hepatitis B
    ClearB Expands Ph1b CLB-4000 Study for Chronic Hepatitis B

    15 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-15/clearb-therapeutics-announces-sentinel-safety-outcome-and-opening-of-the-remainder-of-the-cohort-in

    PHARMIWEB
    15 Oct 2025
    Share Share
    ClearB Therapeutics to Present Pre-Clinical Hepatitis B Data
    ClearB Therapeutics to Present Pre-Clinical Hepatitis B Data

    25 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250425301013/en/ClearB-Therapeutics-Announces-Upcoming-Poster-Presentation-of-Pre-Clinical-Chronic-Hepatitis-B-Data-at-EASL-2025

    BUSINESSWIRE
    25 Apr 2025
    Share Share
    ClearB Announces License With Adjuvance And Preclinical Data Presentations
    ClearB Announces License With Adjuvance And Preclinical Data Presentations

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241017055842/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share
    ClearB Presents Preclinical Chronic Hepatitis B Data At EASL 2024
    ClearB Presents Preclinical Chronic Hepatitis B Data At EASL 2024

    29 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240529689999/en

    BUSINESSWIRE
    29 May 2024
    Share Share
    ClearB Therapeutics Announces First Patient Dosed in a Phase 1b
    ClearB Therapeutics Announces First Patient Dosed in a Phase 1b

    12 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231012033794/en

    BUSINESSWIRE
    12 Oct 2023
    Share Share
    ClearB Announces Upcoming Poster of Pre-Clinical Chronic Hepatitis B
    ClearB Announces Upcoming Poster of Pre-Clinical Chronic Hepatitis B

    20 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230620423889/en

    BUSINESSWIRE
    20 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search